EX-10.18 19 a2215523zex-10_18.htm EX-10.18 EMPLOYMENT AGREEMENT RENEWAL January 10, 2013 Francois Wilhelm, MD, PhDEmployment Agreement • May 5th, 2020 • Pennsylvania
Contract Type FiledMay 5th, 2020 Jurisdiction
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2015 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledMarch 30th, 2015 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is effective as of January 12, 2015 (the “Effective Date”) between Onconova Therapeutics, Inc., a Delaware corporation (hereinafter the “Company”) and Steven Fruchtman, M.D. (hereinafter “Employee”).
EMPLOYMENT AGREEMENT RENEWALEmployment Agreement • June 14th, 2013 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledJune 14th, 2013 Company Industry JurisdictionThis is to extend your Employment Agreement with Onconova Therapeutics, Inc. We wish to renew your agreement to cover the period of June 1, 2012 through May 31st, 2014.
EMPLOYMENT AGREEMENTEmployment Agreement • June 14th, 2013 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledJune 14th, 2013 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is effective as of March 20, 2013 (the “Effective Date”) between Onconova Therapeutics, Inc., a Delaware corporation (hereinafter the “Company”) and Ajay Bansal (hereinafter “Employee”).
EMPLOYMENT AGREEMENT RENEWALEmployment Agreement • June 14th, 2013 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledJune 14th, 2013 Company Industry Jurisdiction
EMPLOYMENT AGREEMENTEmployment Agreement • June 14th, 2013 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledJune 14th, 2013 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is effective as of September 1, 2012 (the “Effective Date”) between Onconova Therapeutics, Inc., a Delaware corporation (hereinafter the “Company”) and Thomas J. McKearn, M.D., Ph.D. (hereinafter “Employee”).